119 related articles for article (PubMed ID: 35066614)
1. RNF43 as a predictor of malignant transformation of pancreatic mucinous cystic neoplasm.
Sakihama K; Koga Y; Yamamoto T; Shimada Y; Yamada Y; Kawata J; Shindo K; Nakamura M; Oda Y
Virchows Arch; 2022 Jun; 480(6):1189-1199. PubMed ID: 35066614
[TBL] [Abstract][Full Text] [Related]
2. Mucinous cystic neoplasms of the liver and pancreas: relationship between KRAS driver mutations and disease progression.
Fujikura K; Akita M; Abe-Suzuki S; Itoh T; Zen Y
Histopathology; 2017 Oct; 71(4):591-600. PubMed ID: 28570009
[TBL] [Abstract][Full Text] [Related]
3. Genomic Characterization of Low- and High-Grade Pancreatic Mucinous Cystic Neoplasms Reveals Recurrent KRAS Alterations in "High-Risk" Lesions.
Conner JR; Mariño-Enríquez A; Mino-Kenudson M; Garcia E; Pitman MB; Sholl LM; Srivastava A; Doyle LA
Pancreas; 2017; 46(5):665-671. PubMed ID: 28196015
[TBL] [Abstract][Full Text] [Related]
4. Deficient Rnf43 potentiates hyperactive Kras-mediated pancreatic preneoplasia initiation and malignant transformation.
Zhou X; Sun Z; Zhang M; Qu X; Yang S; Wang L; Jing Y; Li L; Deng W; Liu F; Di J; Chen J; Wu J; Zhang H
Animal Model Exp Med; 2022 Feb; 5(1):61-71. PubMed ID: 35229994
[TBL] [Abstract][Full Text] [Related]
5. Activated wnt signaling in stroma contributes to development of pancreatic mucinous cystic neoplasms.
Sano M; Driscoll DR; De Jesus-Monge WE; Klimstra DS; Lewis BC
Gastroenterology; 2014 Jan; 146(1):257-67. PubMed ID: 24067880
[TBL] [Abstract][Full Text] [Related]
6. Molecular and clinicopathological features of appendiceal mucinous neoplasms.
Yanai Y; Saito T; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Tomita S; Hirai S; Ogura K; Matsumoto T; Wada R; Yao T
Virchows Arch; 2021 Mar; 478(3):413-426. PubMed ID: 32821969
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate Antigen 19-9 Is an Invasive Malignancy Preoperative Prognostic Factor for Intraductal Papillary Mucinous Neoplasms.
Suzuki S; Shimoda M; Shimazaki J; Oshiro Y; Nishda K; Orimoto N; Nagakawa Y; Tsuchida A
Eur Surg Res; 2021; 62(4):262-270. PubMed ID: 34344012
[TBL] [Abstract][Full Text] [Related]
8. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma.
Jiang X; Hao HX; Growney JD; Woolfenden S; Bottiglio C; Ng N; Lu B; Hsieh MH; Bagdasarian L; Meyer R; Smith TR; Avello M; Charlat O; Xie Y; Porter JA; Pan S; Liu J; McLaughlin ME; Cong F
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12649-54. PubMed ID: 23847203
[TBL] [Abstract][Full Text] [Related]
9. Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4.
Hosoda W; Chianchiano P; Griffin JF; Pittman ME; Brosens LA; Noë M; Yu J; Shindo K; Suenaga M; Rezaee N; Yonescu R; Ning Y; Albores-Saavedra J; Yoshizawa N; Harada K; Yoshizawa A; Hanada K; Yonehara S; Shimizu M; Uehara T; Samra JS; Gill AJ; Wolfgang CL; Goggins MG; Hruban RH; Wood LD
J Pathol; 2017 May; 242(1):16-23. PubMed ID: 28188630
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated Wnt signalling and recurrent mutations of the tumour suppressor RNF43 in early gastric carcinogenesis.
Min BH; Hwang J; Kim NK; Park G; Kang SY; Ahn S; Ahn S; Ha SY; Lee YK; Kushima R; Van Vrancken M; Kim MJ; Park C; Park HY; Chae J; Jang SS; Kim SJ; Kim YH; Kim JI; Kim KM
J Pathol; 2016 Nov; 240(3):304-314. PubMed ID: 27514024
[TBL] [Abstract][Full Text] [Related]
11. GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.
Tan MC; Basturk O; Brannon AR; Bhanot U; Scott SN; Bouvier N; LaFemina J; Jarnagin WR; Berger MF; Klimstra D; Allen PJ
J Am Coll Surg; 2015 May; 220(5):845-854.e1. PubMed ID: 25840541
[TBL] [Abstract][Full Text] [Related]
12. RNF43 mutations are recurrent in Chinese patients with mucinous ovarian carcinoma but absent in other subtypes of ovarian cancer.
Zou Y; Wang F; Liu FY; Huang MZ; Li W; Yuan XQ; Huang OP; He M
Gene; 2013 Nov; 531(1):112-6. PubMed ID: 24001777
[TBL] [Abstract][Full Text] [Related]
13. Mucinous Cystic Neoplasms Lined by Abundant Mucinous Epithelium Frequently Involve KRAS Mutations and Malignant Progression.
Shibata H; Ohike N; Norose T; Isobe T; Suzuki R; Imai H; Shiokawa A; Aoki T; Murakami M; Mizukami H; Tanaka JI; Takimoto M
Anticancer Res; 2017 Dec; 37(12):7063-7068. PubMed ID: 29187496
[TBL] [Abstract][Full Text] [Related]
14. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy.
Jimenez RE; Warshaw AL; Z'graggen K; Hartwig W; Taylor DZ; Compton CC; Fernández-del Castillo C
Ann Surg; 1999 Oct; 230(4):501-9; discussion 509-11. PubMed ID: 10522720
[TBL] [Abstract][Full Text] [Related]
15. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.
Wu J; Jiao Y; Dal Molin M; Maitra A; de Wilde RF; Wood LD; Eshleman JR; Goggins MG; Wolfgang CL; Canto MI; Schulick RD; Edil BH; Choti MA; Adsay V; Klimstra DS; Offerhaus GJ; Klein AP; Kopelovich L; Carter H; Karchin R; Allen PJ; Schmidt CM; Naito Y; Diaz LA; Kinzler KW; Papadopoulos N; Hruban RH; Vogelstein B
Proc Natl Acad Sci U S A; 2011 Dec; 108(52):21188-93. PubMed ID: 22158988
[TBL] [Abstract][Full Text] [Related]
16. RNF43 R117fs mutant positively regulates Wnt/β-catenin signaling by failing to internalize FZD expressed on the cell surface.
Cho AR; Sul HJ; Kim YJ; Kim B; Zang DY
Sci Rep; 2022 Apr; 12(1):7013. PubMed ID: 35487932
[TBL] [Abstract][Full Text] [Related]
17. Genomic characterization of malignant progression in neoplastic pancreatic cysts.
Noë M; Niknafs N; Fischer CG; Hackeng WM; Beleva Guthrie V; Hosoda W; Debeljak M; Papp E; Adleff V; White JR; Luchini C; Pea A; Scarpa A; Butturini G; Zamboni G; Castelli P; Hong SM; Yachida S; Hiraoka N; Gill AJ; Samra JS; Offerhaus GJA; Hoorens A; Verheij J; Jansen C; Adsay NV; Jiang W; Winter J; Albores-Saavedra J; Terris B; Thompson ED; Roberts NJ; Hruban RH; Karchin R; Scharpf RB; Brosens LAA; Velculescu VE; Wood LD
Nat Commun; 2020 Aug; 11(1):4085. PubMed ID: 32796935
[TBL] [Abstract][Full Text] [Related]
18. KRAS, GNAS, and RNF43 mutations in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis.
Lee JH; Kim Y; Choi JW; Kim YS
Springerplus; 2016; 5(1):1172. PubMed ID: 27512631
[TBL] [Abstract][Full Text] [Related]
19.
Chang XY; Wu Y; Jiang Y; Wang PY; Chen J
Gastroenterol Res Pract; 2020; 2020():1457452. PubMed ID: 32934653
[TBL] [Abstract][Full Text] [Related]
20. Implications of pregnancy on MCN of the pancreas: A multicentric case-control study.
Fogliati A; Crippa S; Marchegiani G; Belfiori G; Pea A; Graham RP; Fiorentini G; Tomasoni G; Aleotti F; Kendrick ML; Salvia R; Falconi M; Truty MJ
Pancreatology; 2024 Apr; ():. PubMed ID: 38702207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
